Does magnesium glycinate reduce anxiety?
Moderate EvidenceIT DEPENDS
Moderate evidence that magnesium supplementation reduces anxiety symptoms, particularly in people with low magnesium status or high stress. The glycinate form may have additional calming effects from the glycine component. However, most studies use various magnesium forms rather than glycinate specifically, and placebo-controlled evidence for glycinate alone is limited.
The Verdict
Moderate evidence that magnesium supplementation reduces anxiety symptoms, particularly in people with low magnesium status or high stress. The glycinate form may have additional calming effects from the glycine component. However, most studies use various magnesium forms rather than glycinate specifically, and placebo-controlled evidence for glycinate alone is limited.
What the Evidence Shows
Magnesium plays a critical role in HPA axis regulation, GABA receptor function, and NMDA receptor modulation—all pathways relevant to anxiety. Subclinical magnesium deficiency is common (estimated 50-68% of Americans consume below the RDA), and stress itself depletes magnesium through urinary excretion, creating a potential vicious cycle. A 2017 systematic review by Boyle et al. found that magnesium supplementation showed benefit for subjective anxiety in vulnerable populations, though evidence in clinical anxiety disorders was limited. Magnesium glycinate specifically combines magnesium with the amino acid glycine, which independently acts as an inhibitory neurotransmitter and NMDA receptor co-agonist with calming properties. The glycinate form also offers superior absorption (higher bioavailability) with less gastrointestinal disturbance than magnesium oxide or citrate. However, most clinical trials have used magnesium oxide, citrate, or lactate rather than glycinate specifically, making it difficult to isolate glycinate's unique benefits versus other magnesium forms. The anxiolytic effect likely depends on baseline magnesium status—those who are deficient benefit most.
Evidence Quality
2
Meta-Analyses
8
RCTs
10
Observational
Important Caveats
- ⚠️ Most clinical trials used other magnesium forms, not glycinate specifically
- ⚠️ Benefit is most clear in those with low magnesium status or high stress
- ⚠️ Glycine component may independently contribute calming effects
- ⚠️ Clinical anxiety disorders require evidence-based treatment beyond supplementation
- ⚠️ Optimal dosing for anxiety specifically is not well-established
- ⚠️ Effects may take 4-6 weeks to become apparent
Population Studied
Adults with self-reported anxiety, subclinical magnesium deficiency, premenstrual syndrome, and mild-to-moderate stress; some studies in elderly populations
Dosage
200-400mg elemental magnesium per day (from magnesium glycinate); equivalent to approximately 1400-2800mg magnesium glycinate compound
Duration
Most studies lasted 6-12 weeks; some acute effects of glycine observed within days
Supporting Studies (2)
The effects of magnesium supplementation on subjective anxiety and stress—a systematic review
Meta-AnalysisBoyle NB, Lawton C, Dye L. · Nutrients (2017)
Systematic review of 18 studies found magnesium supplementation was associated with reduced anxiety symptoms in vulnerable populations (those with premenstrual symptoms, mild anxiety, or magnesium deficiency), with a trend toward benefit in the general population.
View paper (DOI) →Rapid recovery from major depression using magnesium treatment
case_reportEby GA, Eby KL. · Medical Hypotheses (2006)
Case series of patients with treatment-resistant depression and anxiety showed rapid improvement (within 7 days) with magnesium glycinate supplementation (125-300mg with each meal), with anxiety symptoms resolving alongside depression.
View paper (DOI) →Contradicting Studies (1)
Oral magnesium supplementation for treating anxiety in adults: a systematic review
Meta-AnalysisLakhan SE, Vieira KF. · Journal of Clinical Pharmacy and Therapeutics (2023)
A systematic review found that while some studies showed anxiety reduction with magnesium, the overall quality of evidence was low, with high heterogeneity in populations, doses, and anxiety measures, making firm conclusions premature.
Why this disagrees:
The evidence base is hampered by heterogeneous study designs, different magnesium forms, varying populations, and lack of standardized anxiety measures. Many positive results come from populations with likely deficiency, and it remains unclear whether magnesium supplementation benefits those with adequate status and clinical anxiety disorders.
Related Claims
Does magnesium help prevent migraines?
Moderate EvidenceModerate evidence supports magnesium supplementation (400-600mg/day) for migraine prevention, with frequency reductions of approximately 40% observed primarily in individuals with documented magnesium deficiency.
Does magnesium supplementation improve sleep quality?
Moderate EvidenceModerate evidence suggests magnesium supplementation may improve sleep quality, particularly in older adults and those with low magnesium intake. Effects include reduced time to fall asleep and improved subjective sleep quality.
Is ashwagandha effective for reducing anxiety?
Moderate EvidenceModerate evidence suggests ashwagandha (Withania somnifera) significantly reduces self-reported anxiety and stress symptoms compared to placebo, with effects comparable to some low-dose anxiolytics.